Takeda Pharmaceutical Company Limited Stock

Equities

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-05-27 EDT 5-day change 1st Jan Change
4,131 JPY -0.07% Intraday chart for Takeda Pharmaceutical Company Limited -0.82% +1.90%

Financials

Sales 2024 4,264B 27.18B 37.09B Sales 2025 * 4,161B 26.52B 36.2B Capitalization 6,486B 41.34B 56.43B
Net income 2024 144B 918M 1.25B Net income 2025 * 127B 811M 1.11B EV / Sales 2024 1.54 x
Net Debt 2024 * 3,771B 24.03B 32.81B Net Debt 2025 * 4,125B 26.29B 35.88B EV / Sales 2025 * 2.57 x
P/E ratio 2024
45.4 x
P/E ratio 2025 *
45.8 x
Employees 49,095
Yield 2024 *
4.55%
Yield 2025 *
4.62%
Free-Float 99.12%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Takeda Pharmaceutical Company Limited

1 day-0.07%
1 week-0.82%
Current month-0.53%
1 month-0.53%
3 months-7.79%
6 months-1.78%
Current year+1.90%
More quotes
1 week
4 072.00
Extreme 4072
4 169.00
1 month
4 018.00
Extreme 4018
4 205.00
Current year
4 018.00
Extreme 4018
4 494.00
1 year
3 900.00
Extreme 3900
4 873.00
3 years
2 993.00
Extreme 2993
4 873.00
5 years
2 894.50
Extreme 2894.5
4 873.00
10 years
2 894.50
Extreme 2894.5
6 693.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 14-03-31
Chief Tech/Sci/R&D Officer 45 22-01-31
Compliance Officer 54 11-12-31
Members of the board TitleAgeSince
Director/Board Member 71 16-05-31
Director/Board Member 62 18-12-31
Director/Board Member 71 18-12-31
More insiders
Date Price Change Volume
24-05-27 4,131 -0.07% 1 511 300
24-05-24 4,134 0.00% 2,457,600
24-05-23 4,134 +0.78% 2,722,100
24-05-22 4,102 -0.75% 2,557,900
24-05-21 4,133 -0.77% 2,527,700

Delayed Quote Japan Exchange, May 27, 2024 at 02:00 am

More quotes
Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas: - sale of drugs and consumer care products; - services. Net sales are distributed geographically as follows: Japan (17.5%), Asia (5%), the United States (49%), Europe and Canada (20.8%), Latin America (3.8%), Russia and CIS (1.8%) and other (2.1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
4,134 JPY
Average target price
4,801 JPY
Spread / Average Target
+16.14%
Consensus